Back
Simmons First National Vs. Cidara Therapeutics Industry Stock Comparison
Buy
61
SFNC
Simmons First National
Last Price:
$20.11
Seasonality Move:
2.47%
Buy
72
CDTX
Cidara Therapeutics
Last Price:
$60.88
Seasonality Move:
-8.92%
Buy
61
Simmons First National (SFNC)
is a Buy
Is Simmons First National a Buy, Sell or Hold?
-
The current Simmons First National [SFNC] share price is $19.69. The Score for SFNC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
SFNC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $56.15. The Score for CDTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SFNC Stock Price Chart
What is Simmons First National's stock price today?
-
The Simmons First National share price today is $19.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFNC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $56.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SFNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.48 | Buy |
Relative Strength Index (14 RSI): | 53.77 | Buy |
Chaikin Money Flow: | 1342226 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.54 - 19.98) | Buy |
Bollinger Bands (100): | (18.41 - 20.57) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.5 | Buy |
Relative Strength Index (14 RSI): | 75 | Buy |
Chaikin Money Flow: | 501835 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.95 - 54.79) | Buy |
Bollinger Bands (100): | (15.79 - 37.97) | Buy |
SFNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.89 | Sell |
20-day SMA: | 19.43 | Buy |
50-day SMA: | 19.24 | Buy |
200-day SMA: | 21.24 | Sell |
8-day EMA: | 17.12 | Buy |
20-day EMA: | 10.93 | Buy |
50-day EMA: | 5.44 | Buy |
200-day EMA: | 1.53 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.26 | Buy |
20-day SMA: | 47.08 | Buy |
50-day SMA: | 32.62 | Buy |
200-day SMA: | 22.48 | Buy |
8-day EMA: | 52.19 | Buy |
20-day EMA: | 46.5 | Buy |
50-day EMA: | 36.83 | Buy |
200-day EMA: | 24.84 | Buy |
Simmons First National Earnings Growth & SFNC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.15 per share, and an increase next year of $0.30 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Simmons First National Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |